Clinical Trials
3 trialsNCT02731352 2022-01-20
Study of Apatinib in Patients With Differentiated Thyroid Cancer
Peking Union Medical College Hospital
Phase 2 Completed
NCT04612894 2020-11-03
Camrelizumab and Apatinib for Neoadjuvant Therapy in Thyroid Cancer
Fudan University
Phase 2 Unknown
NCT03300765 2017-10-03
Trail Evaluating Apatinib With IMRT for Inoperable or Iodine Refractory Thyroid Cancer
Fudan University
Phase 2 Unknown